Paper2909415
Kidney hemodynamics after ketone body and amino acid infusion in normal and IDDM subjects.
Nosadini R and 9 others. Diabetes, 1989. Cited by 47 papers, by iCite.
Cite this record
ConductScience Library. Kidney hemodynamics after ketone body and amino acid infusion in normal and IDDM subjects. Papers, record 2909415. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2909415
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Kidney hemodynamics after ketone body and amino acid infusion in normal and IDDM subjects.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amino Acids | Major topic |
| Diabetes Mellitus, Type 1 | Major topic |
| Ketone Bodies | Major topic |
| Renal Circulation | Major topic |
| Adult | |
| Female | |
| Glomerular Filtration Rate | |
| Humans | |
| Kidney | |
| Lithium | |
| Male | |
| Middle Aged | |
| Serum Albumin | |
| Sodium |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36139492 | Diabetic Proteinuria Revisited: Updated Physiologic Perspectives. | Cells | 2022 | https://conductscience.org/library/papers/36139492 | PubMed |
| 35409011 | An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35409011 | PubMed |
| 35351189 | The clinical efficacy and safety of dapagliflozin in patients with diabetic nephropathy. | Diabetol Metab Syndr | 2022 | https://conductscience.org/library/papers/35351189 | PubMed |
| 34621766 | A Systematic Review of Intravenous β-Hydroxybutyrate Use in Humans - A Promising Future Therapy? | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/34621766 | PubMed |
| 15980943 | Glomerular function reserve and sodium sensitivity. | Clin Exp Nephrol | 2005 | https://conductscience.org/library/papers/15980943 | PubMed |
| 15143864 | Renal functional reserve in patients with Type 1 diabetes mellitus. | Wien Klin Wochenschr | 2004 | https://conductscience.org/library/papers/15143864 | PubMed |
| 8877292 | Effects of insulin and lipid emulsion on renal haemodynamics and renal sodium handling in IDDM patients. | Diabetologia | 1996 | https://conductscience.org/library/papers/8877292 | PubMed |
| 8359579 | Glucose-induced changes in renal haemodynamics in proteinuric type 1 (insulin-dependent) diabetic patients: inhibition by acetylsalicilic acid infusion. | Diabetologia | 1993 | https://conductscience.org/library/papers/8359579 | PubMed |
| 1936664 | Impaired response to angiotensin II in type 1 (insulin-dependent) diabetes mellitus. Role of prostaglandins and sodium-lithium countertransport activity. | Diabetologia | 1991 | https://conductscience.org/library/papers/1936664 | PubMed |
| 1769444 | Effect of captopril on renal functional reserve in type 1 (insulin-dependent) diabetes mellitus. | Diabetologia | 1991 | https://conductscience.org/library/papers/1769444 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2909415
GET https://conductscience.org/api/papers/v1/2909415/authors